#
Atrovent Inhalation, oral/nebulization
  • Treatments
  • COPD
  • Maintenance

Atrovent

Generic name:ipratropium (inhalation route) [ ip-ra-TROE-pee-um-BROE-mide ]
Drug class:Anticholinergic bronchodilators

Medically reviewed by Drugs.com. Last updated on May 4, 2022.

Commonly used brand name(s)

In the U.S.

  • Atrovent

In Canada

  • Alti-Ipratropium
  • Alti-Ipratropium With Preservative
  • Apo-Ipravent
  • Ipratropium Bromide Nebuamp
  • Ipratrovent Sterules
  • Ratio-Ipratropium
  • Ratio-Ipratropium Udv

Available Dosage Forms:

  • Solution

Therapeutic Class: Bronchodilator

Pharmacologic Class: Ipratropium

Uses for Atrovent

Ipratropium is used to help control the symptoms of lung diseases, such as asthma, chronic bronchitis, and emphysema. It is also used to treat air flow blockage and prevent the worsening of chronic obstructive pulmonary disease (COPD).

Ipratropium belongs to the family of medicines known as bronchodilators. Bronchodilators are medicines that are breathed in through the mouth to open up the bronchial tubes (air passages) in the lungs.

This medicine is available only with your doctor's prescription.

Before using Atrovent

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Appropriate studies have not been performed on the relationship of age to the effects of ipratropium in the pediatric population. Safety and efficacy have not been established.

Geriatric

Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of ipratr...